Abstract:The predominant opioid receptor subtypes in heart tissue are delta and kappa opioid receptors. Activation of delta and kappa opioid receptors during preconditioning have been shown to reduce infarct size in myocardial ischemia reperfusion (I/R) injury. This cardioprotective effect has been abolished with naloxone (NX), a broad-spectrum opioid receptor antagonist (e.g., delta, kappa, and mu). Previously, we demonstrated that a novel tripeptide, structurally similar to other delta or kappa opioid peptide receptor agonists, when given prior to global ischemia, significantly reduced infarct size and improved post-reperfused cardiac function using a Langendorf rat I/R heart ex vivo model. To identify the opioid receptor subtype responsible for tripeptide's cardioprotective effects, we used naltrindole (NTI), a selective delta opioid receptor antagonist. The cardioprotective effects of tripeptide were blocked by NX, but not NTI. To determine whether the cardioprotective effects of the combination was due to tripeptide or NTI, the effects of NTI and NX were evaluated individually in the same model. Male Sprague-Dawley rats (~300g) were subjected to global I(30min)/R(50min). NX (10 μM, n=6) or NTI (5 μM, n=8) or H2O vehicle (control n= 10) were given to hearts 5 min prior to ischemia and during the first 5 min of reperfusion in a Langendorf perfused model. Left ventricular (LV) cardiac function indices were measured using a pressure transducer. At the end of reperfusion (50min), hearts were frozen, sectioned (2 mm), and stained with 1% triphenyltetrazolium chloride (TTC). Infarcted heart tissue was compared to total tissue weight. Data were evaluated using ANOVA Student-Newman-Keuls post-hoc analysis. Control hearts (n=10) exhibited increased final LV end diastolic pressure (LVEDP) of 60±5 mmHg from baseline values (~8mmHg for all groups) and a mean infarct size of 36 ± 3% at 50 min post-reperfusion. NX showed no significant cardioprotective effect, since final LVEDP (64 ± 5%) and infarct size (35 ± 5%) was similar to control hearts. Surprisingly, the selective delta opioid antagonist, NTI, remarkably improved final LVEDP to 17 ± 3mmHg to near baseline values and reduced infarct size to 7 ± 2% compared to control and NX hearts (both p<0.01). The results indicate that NTI can prevent ischemic injury and restore post-reperfused heart function to pre-ischemic levels. In future studies, we will examine the intracellular mechanisms of NTI responsible for preventing myocardial ischemic injury.

The Role of δ2-Opioid Receptors in the Regulation of Tolerance of Isolated Cardiomyocytes to Hypoxia and Reoxygenation

Activation of Cardiac δ2-Opioid Receptors Increases Heart Tolerance to Reperfusion

Inhibition of Mitochondrial Permeability Transition Pore Opening Mediated by Kappa‐opioid Receptor in Cardioprotection by Remote Preconditioning

The Role of Cardiac Opioid Receptors in the Cardioprotective Effect of Continuous Normobaric Hypoxia

Opioid Receptor-Mediated Effects of Interleukin-2 on the [ca2+]i Transient and Contraction in Isolated Ventricular Myocytes of the Rat

The Infarct-Reducing Effect of the δ2 Opioid Receptor Agonist Deltorphin II: The Molecular Mechanism

Role of Opioid Receptor in Cardioprotection after Ischemia-Reperfusion During Cardiopulmonary Bypass

Effect and Mechanism of Opioid Receptor Antagonist on Allograft Rejection

Continuous Normobaric Hypoxia Improved Cardiac Bioenergetics after Ischemia/Reperfusion: Role of Opioid Receptors

δ-Opioid receptors: Pivotal role in intermittent hypoxia-augmentation of cardiac parasympathetic control and plasticity

Comparative Analysis of Infarct-Limiting Activity of Peptide and Non-Peptide δ- and κ-Opioid Receptor Agonists during Heart Reperfusion In Vivo

Naltrindole Exhibits Robust Cardioprotection in Myocardial Ischemia Reperfusion Injury

Role of Opioid Δ1receptors, Mitochondrial KATPChannels, and Protein Kinase C During Cardiocyte Apoptosis

Kappa Opioid Receptor Mediates The Cardioprotection Of Posteonditioning In The Isolated Rat Heart Subjected To Ischemia And Reperfusion

Abstract P2173: Naltrindole Offers Potent Cardioprotection from Ischemia Reperfusion Injury; Opioid Antagonism or Calcium Handling?

Kappa-Opioid Receptors Mediate Cardioprotection by Remote Preconditioning

Role of Nrf2/ARE Pathway in Morphine Preconditioning to Alleviate Rat Myocardial Ischemia-Reperfusion Injury

Involvement of Opioid Receptors in Ischemic Postconditioning in the Isolated Rat Hearts

24-hour pretreatment with delta opioid enhances survival from hemorrhagic shock

Role of Δ-Opioid Receptors in Hydromorphone Postconditioning-Induced Maintenance of Electrophysio-Logical Stability During Ischemia-Reperfusion in Isolated Rat Hearts

Role of Opioid Receptors in Protective Effects of Isoflurane- Induced Delayed Preconditioning Against Myocardial Ischemia-Reperfusion Injury in Rabbits